Insmed (INSM) Change in Accured Expenses (2010 - 2026)
Insmed (INSM) recorded quarterly Change in Accured Expenses of -$497000.0 in Q1 2026, up 96.62% quarter-over-quarter from -$14.7 million in Q4 2025, and up 99.19% on a YoY basis from -$249508.3 in Q1 2025.
Insmed (INSM) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Insmed's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$497000.0 for Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 99.19% year-over-year to -$497000.0; the TTM figure through Mar 2026 stood at $56.0 million (up 620.75% YoY), while the FY2025 annual figure was -$5.0 million, down 111.19% from the prior year.
- Change in Accured Expenses was -$497000.0 for Q1 2026 at Insmed, up from -$14.7 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $58.5 million in Q2 2025 to a low of -$61.5 million in Q1 2025.
- Historically, Change in Accured Expenses has averaged $2.5 million across 5 years, with a median of $725000.0 in 2024.
- Biggest YoY gain for Change in Accured Expenses was 1652.97% in 2025; the steepest drop was 900.81% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at -$27.7 million in 2022, then soared by 178.31% to $21.7 million in 2023, then soared by 89.46% to $41.1 million in 2024, then plunged by 135.79% to -$14.7 million in 2025, then jumped by 96.62% to -$497000.0 in 2026.
- The last three Change in Accured Expenses figures came in at -$497000.0 (Q1 2026), -$14.7 million (Q4 2025), and $12.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 931,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | -497,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -497,000.00 |
| Mar 31, 2026 | -497,000.00 |
| Dec 31, 2025 | -14.72 Mn |
| Dec 31, 2025 | -14.72 Mn |
| Sep 30, 2025 | 12.71 Mn |
| Sep 30, 2025 | 12.71 Mn |
| Jun 30, 2025 | 58.51 Mn |
| Jun 30, 2025 | 58.51 Mn |
| Mar 31, 2025 | -61.49 Mn |
| Mar 31, 2025 | -61.49 Mn |
| Dec 31, 2024 | 41.13 Mn |
| Dec 31, 2024 | 41.13 Mn |
| Sep 30, 2024 | 725,000.00 |
| Sep 30, 2024 | 725,000.00 |
| Jun 30, 2024 | 8.88 Mn |
| Jun 30, 2024 | 8.88 Mn |
| Mar 31, 2024 | -6.14 Mn |
| Mar 31, 2024 | -6.14 Mn |
| Dec 31, 2023 | 21.71 Mn |
| Dec 31, 2023 | 21.71 Mn |